Immunology and Microbiology
T Cell
100%
Cytotoxic T-Cell
44%
DNA Barcoding
28%
Severe Acute Respiratory Syndrome Coronavirus 2
25%
Vaccination Policy
24%
Antigen Specificity
23%
Adoptive Immunity
20%
Myeloid
20%
Major Histocompatibility Complex
19%
Epitope
19%
COVID-19
18%
Omicron Coronavirus Variant
18%
Endogenous Retrovirus
18%
Neoantigen
15%
Antigen Recognition
14%
Vaccine Efficacy
11%
T Cell Activation
10%
Immunodominance
10%
Viral Disease
10%
Mutational Load
9%
Epigenetics
9%
Immune Checkpoint Blockade
9%
Cancer Immunotherapy
9%
Immunoreactivity
9%
Histocompatibility Complex
9%
T Cell Receptor
9%
T-Helper Cell
9%
Cell Differentiation
9%
Liver Transplantation
9%
Epitope Mapping
9%
Immunopeptidomics
9%
Immunodeficiency
8%
Cancer Cell
7%
Cell Population
6%
Tumor Antigen
5%
Keyphrases
T Cells
20%
Immunocompromised State
18%
CD8+ T Cells
18%
SARS-CoV-2 mRNA Vaccination
13%
Antigen-specific T Cells
13%
Dysplastic Cells
9%
Antigen-responsive
9%
Cell-intrinsic
9%
T Cell Response
9%
Anamnestic
9%
BNT162b2
9%
COVID-19 mRNA Vaccine
9%
Human Endogenous Retrovirus
9%
Solid Organ Transplant Recipients
9%
T Cell Recognition
9%
Tumor mutational Burden
9%
Large-scale Detection
9%
Atezolizumab
9%
Immune Checkpoint Blockade
9%
PMHC
9%
Relapsed or Refractory
9%
Guadecitabine
9%
DNA Barcoding
9%
Specific T Cells
9%
Multimers
9%
MHC Class II
9%
Viral Infection
9%
Antigen-specific
9%
Immunodeficiency
6%
Spike Antigen
6%
Varicella Zoster Virus
5%
Medicine and Dentistry
T Cell
31%
Endogenous Retrovirus
18%
Neoplasm
13%
Myelodysplastic Syndrome
13%
Virus Infection
10%
Non Small Cell Lung Cancer
9%
Antigen Recognition
9%
Hematologic Malignancy
9%
Nodular Melanoma
9%
Hematological Cancer
9%
Atezolizumab
9%
Guadecitabine
9%
Chronic Myelomonocytic Leukemia
9%
Cancer Immunotherapy
9%
Liver Graft
9%
Liver Transplantation
9%
Malignant Neoplasm
9%
Antigen Specificity
9%
Mutational Load
7%
Cytotoxic T-Cell
6%
Cancer Cell
6%
Varicella Zoster Virus
5%
